Has Sendhan Rajamanickam received payments from drug or device companies?

Yes. Drug and device makers reported $16,266 in general payments to Sendhan Rajamanickam across 120 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sendhan Rajamanickam did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sendhan Rajamanickam come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sendhan Rajamanickam

Orthopaedic Surgery · Rochester, NYNPI 1508108192

Payments from drug & device makers

$16,266in general payments, 2019–2025

Across 120 payments — averaging $135.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$11K
Smith+Nephew$3K
Stryker$1K
Prodigy Surgical Distribution, Inc.$825
Johnson & Johnson$777
Davol Inc.$143
plus $159 from 3 others

What the payments were for

Travel & lodging$8,67953%
Food & beverage$6,52440%
Education$1,0637%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	87	$10,772
Smith+Nephew	13	$2,504
Stryker	12	$1,085
Prodigy Surgical Distribution, Inc.	1	$825
Johnson & Johnson	2	$777
Davol Inc.	1	$143
Medical Device Business Services, Inc.	2	$71
Next Science LLC	1	$63
Conmed Corporation	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,266 in reported general payments places this provider in the 70th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$36,605

Medicare patients

Services billed

1,110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	25	$183
Oxycodone Hcl	35	$183
Meloxicam	32	$140
Methylprednisolone	14	$117
Cephalexin	17	$77
Tramadol Hcl	19	$51

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rochester

Brian GiordanoRochester$1M
Anthony RomeoNew York$27M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$14.1M
William RicciNew York$11.6M
Steven HaasNew York$11.5M
Giles ScuderiNew York$10.9M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →